BNTX insider ownership: who sold, why, and what they still hold

What stands out

Selling picked up in the last 90 days: officers and directors sold 858K shares, against an average of 16K per 90 days earlier in the period. Most of it was Ugur Sahin (858K shares in the last 90 days); 100% of these sales were under disclosed plans.Ugur Sahin: largest recent sale, Oct 5, 2026

A share of stake is shown for 0 of the 2 officers and directors who sold. 11 are left out

Left out: Ugur Sahin, Helmut Jeggle, Sierk Poetting, James Ryan, Ulrich Wandschneider, Rudolf Staudigl, Anja Morawietz, Annemarie Hanekamp, Ozlem Tureci, Kylie Jimenez and Gomez Zapata (share of stake is being verified).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.

Ugur Sahin

Chief Executive Officer

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$84.2MDisclosed plan

Sierk Poetting

Chief Operating Officer

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$5.5MDisclosed plan

Amounts, filings and trading plans for each seller

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled

Recent activity

Past 30 days, Sep 14, 2026 to Oct 13, 2026

Oct 9, 2026Ugur Sahin sold 36K shares ($3.5M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	36,209	$95.37	n/a	n/a	Oct 9, 2026	Oct 9, 2026

Oct 8, 2026Ugur Sahin sold 27K shares ($2.5M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	27,000	$92.31	n/a	n/a	Oct 8, 2026	Oct 9, 2026

Oct 7, 2026Ugur Sahin sold 24K shares ($2.3M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	24,000	$95.86	n/a	n/a	Oct 7, 2026	Oct 7, 2026

Oct 6, 2026Ugur Sahin sold 21K shares ($2.0M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	21,000	$96.81	n/a	n/a	Oct 6, 2026	Oct 6, 2026

Oct 5, 2026Ugur Sahin sold 72K shares ($7.0M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	72,000	$97.23	n/a	n/a	Oct 5, 2026	Oct 6, 2026

Show all 20 events

Oct 2, 2026Ugur Sahin sold 17K shares ($1.6M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	17,000	$96.72	n/a	n/a	Oct 2, 2026	Oct 2, 2026

Oct 1, 2026Ugur Sahin sold 17K shares ($1.7M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	17,000	$97.46	n/a	n/a	Oct 1, 2026	Oct 2, 2026

Sep 30, 2026Ugur Sahin sold 32K shares ($3.1M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	32,000	$98.12	n/a	n/a	Sep 30, 2026	Sep 30, 2026

Sep 29, 2026Ugur Sahin sold 34K shares ($3.3M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	34,000	$98.26	n/a	n/a	Sep 29, 2026	Sep 30, 2026

Sep 28, 2026Ugur Sahin sold 34K shares ($3.3M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	34,000	$98.47	n/a	n/a	Sep 28, 2026	Sep 28, 2026

Sep 25, 2026Ugur Sahin sold 27K shares ($2.7M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	27,000	$98.69	n/a	n/a	Sep 25, 2026	Sep 28, 2026

Sep 24, 2026Ugur Sahin sold 39K shares ($3.9M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	39,000	$98.99	n/a	n/a	Sep 24, 2026	Sep 24, 2026

Sep 23, 2026Ugur Sahin sold 30K shares ($3.0M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	30,000	$99.40	n/a	n/a	Sep 23, 2026	Sep 24, 2026

Sep 22, 2026Ugur Sahin sold 46K shares ($4.6M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	46,000	$100.72	n/a	n/a	Sep 22, 2026	Sep 22, 2026

Sep 21, 2026Ugur Sahin sold 33K shares ($3.2M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	33,000	$97.81	n/a	n/a	Sep 21, 2026	Sep 22, 2026

Sep 18, 2026Ugur Sahin sold 30K shares ($2.9M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	30,000	$96.22	n/a	n/a	Sep 18, 2026	Sep 18, 2026

Sep 17, 2026Ugur Sahin sold 34K shares ($3.4M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	34,000	$98.60	n/a	n/a	Sep 17, 2026	Sep 18, 2026

Sep 16, 2026Ugur Sahin sold 15K shares ($1.4M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	15,000	$96.09	n/a	n/a	Sep 16, 2026	Sep 16, 2026

Sep 15, 2026Ugur Sahin sold 34K shares ($3.3M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	34,000	$96.49	n/a	n/a	Sep 15, 2026	Sep 16, 2026

Sep 14, 2026Ugur Sahin sold 41K shares ($4.1M) under a disclosed trading plan.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Ugur Sahin Chief Executive Officer	41,000	$99.45	n/a	n/a	Sep 14, 2026	Sep 14, 2026

"% of total stake" is the shares in an event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings are not confirmed, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.

Common questions

Is the BioNTech SE CEO selling stock?

Yes. Ugur Sahin sold 858K shares ($84.2M) in the past 12 months, all of it under a trading plan disclosed in the filings.

Why are BioNTech SE insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 100% of sales by value ran under 10b5-1 trading plans disclosed in the filings. A trading plan schedules sales in advance.

Are any BioNTech SE insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

The evidence

Who sold2 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Ugur Sahin Chief Executive Officer	$84.2M 858K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Sierk Poetting Chief Operating Officer	$5.5M 50K shares	Not confirmed share of stake is being verified. Why	Disclosed plan

The full ownership picture0 of 11 officers and directors confirmed

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 13, 2025

Sold

Held Oct 13, 2026

Still held

Ugur Sahin

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for Ugur Sahin are complete.

Chief Executive Officer

n/a

−858K

n/a

Vesting, gifts, unvested awards and holding lines for Ugur Sahin

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Ugur Sahin are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
38,506	$113.94	May 22, 2033	$0
53,233	n/a	Aug 26, 2034	n/a
18,747	n/a	May 28, 2035	n/a

Estimate: options held × ($95.37 − strike price), using the most recent insider trade price on Form 4 (Oct 9, 2026), not a market close.

Helmut Jeggle

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Helmut Jeggle are complete.

Director

n/a

Vesting, gifts, unvested awards and holding lines for Helmut Jeggle

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Helmut Jeggle are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Sierk Poetting

Chief Operating Officer

n/a

−50K

n/a

Vesting, gifts, unvested awards and holding lines for Sierk Poetting

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Sierk Poetting are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
18,416	$113.94	May 22, 2033	$0
25,459	n/a	Aug 26, 2034	n/a
8,838	n/a	May 28, 2035	n/a
12,586	n/a	May 12, 2036	n/a

Estimate: options held × ($95.37 − strike price), using the most recent insider trade price on Form 4 (Oct 9, 2026), not a market close.

James Ryan

Chief Legal Officer and Chief Business Officer

n/a

Vesting, gifts, unvested awards and holding lines for James Ryan

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for James Ryan are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
25,459	n/a	Aug 26, 2034	n/a
8,838	n/a	May 28, 2035	n/a
12,586	n/a	May 12, 2036	n/a

Estimate: options held × ($95.37 − strike price), using the most recent insider trade price on Form 4 (Oct 9, 2026), not a market close.

Ulrich Wandschneider

Director

n/a

Vesting, gifts, unvested awards and holding lines for Ulrich Wandschneider

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Ulrich Wandschneider are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Rudolf Staudigl

Director

n/a

Vesting, gifts, unvested awards and holding lines for Rudolf Staudigl

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Rudolf Staudigl are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Anja Morawietz

Director

n/a

Vesting, gifts, unvested awards and holding lines for Anja Morawietz

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Anja Morawietz are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Annemarie Hanekamp

Chief Commercial Officer

n/a

Vesting, gifts, unvested awards and holding lines for Annemarie Hanekamp

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Annemarie Hanekamp are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
8,838	n/a	May 28, 2035	n/a
12,586	n/a	May 12, 2036	n/a

Estimate: options held × ($95.37 − strike price), using the most recent insider trade price on Form 4 (Oct 9, 2026), not a market close.

Ozlem Tureci

Chief Medical Officer

n/a

Vesting, gifts, unvested awards and holding lines for Ozlem Tureci

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Ozlem Tureci are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
18,416	$113.94	May 22, 2033	$0
25,459	n/a	Aug 26, 2034	n/a
9,306	n/a	May 28, 2035	n/a

Estimate: options held × ($95.37 − strike price), using the most recent insider trade price on Form 4 (Oct 9, 2026), not a market close.

Kylie Jimenez

Chief People Officer

n/a

Vesting, gifts, unvested awards and holding lines for Kylie Jimenez

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Kylie Jimenez are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
10,488	n/a	May 12, 2036	n/a

Estimate: options held × ($95.37 − strike price), using the most recent insider trade price on Form 4 (Oct 9, 2026), not a market close.

Gomez Zapata

Chief Financial Officer

n/a

Vesting, gifts, unvested awards and holding lines for Gomez Zapata

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Gomez Zapata are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
18,879	n/a	May 12, 2036	n/a

Estimate: options held × ($95.37 − strike price), using the most recent insider trade price on Form 4 (Oct 9, 2026), not a market close.

Holdings and share of stake for BioNTech SE are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.

What explains the selling$89.8M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $89.8M across 908,209 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $89.8M · 100%

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Ugur Sahin Chief Executive Officer	858K	$84.2M	100%	94%	Sep 3, 2026 to Oct 9, 2026
Sierk Poetting Chief Operating Officer	50K	$5.5M	100%	6%	Apr 22, 2026 to Apr 22, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$0	$0	$0	$0
Dec 2025	$0	$0	$0	$0
Jan 2026	$0	$0	$0	$0
Feb 2026	$0	$0	$0	$0
Mar 2026	$0	$0	$0	$0
Apr 2026	$5.5M	$5.5M	$0	$0
May 2026	$0	$0	$0	$0
Jun 2026	$0	$0	$0	$0
Jul 2026	$0	$0	$0	$0
Aug 2026	$0	$0	$0	$0
Sep 2026	$63.7M	$63.7M	$0	$0
Oct 2026	$20.6M	$20.6M	$0	$0

Known gaps and uncertainty11 officers and directors not confirmed

Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for BioNTech SE are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology36 filings on record, 36 filed in the 12-month period, and how we read them

All 36 Forms 3, 4 and 5 on record for BioNTech SE (SEC CIK 1776985), filed from Mar 18, 2026 to Oct 9, 2026; 36 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 13, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (4)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Michael Motschmann		No balance on record
Nicola Blackwood		No balance on record
Susanne Schaffert		No balance on record
Iris Low-Friedrich		No balance on record

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

BioNTech SE insiders sold $89.8M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Recent activity

Common questions

Is the BioNTech SE CEO selling stock?

Why are BioNTech SE insiders selling?

Are any BioNTech SE insiders buying?

The evidence

Sales by month